Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy

A. M.M. Eggermont, V. Chiarion-sileni, J. J. Grob, R. Dummer, J. D. Wolchok, H. Schmidt, O. Hamid, C. Robert, P. A. Ascierto, J. M. Richards, C. Lebbé, V. Ferraresi, M. Smylie, J. S. Weber, M. Maio, L. Bastholt, L. Mortier, L. Thomas, S. Tahir, A. HauschildJ. C. Hassel, F. S. Hodi, C. Taitt, V. De Pril, G. De Schaetzen, S. Suciu, A. Testori

Research output: Contribution to journalArticlepeer-review

1095 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science